EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy

Rosario Marchese-Ragona iD, Gianmarco Giunta iD, Daniela Adamo, Elisabetta Zanoletti, Daniele Manfredini iD, Domenico Antonio Restivo

Head & Neck · 2026-12 · 48 (12) · 3447-3455

DOI: 10.1002/hed.70378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, online erschienen am 01.07.2026. Verfasst von Rosario Marchese-Ragona und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Otorhinolaryngology-Head and Neck Surgery, Department of Neuroscience (DNS), University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate botulinum toxin type A (BoNT‐A) for First Bite Syndrome (FBS) and assess a symptom‐guided “Follow‐the‐Pain” (FTP) injection strategy in patients with incomplete response to standard treatment.

Methods

Consecutive patients with postoperative FBS were treated with ultrasound‐guided intraparotid BoNT‐A injection. Patients with partial or poor response received additional targeted injections (15–25 U) at patient‐reported sites of maximal pain using the FTP protocol. Pain intensity was assessed using a Visual Analog Scale (VAS), and outcomes were monitored with a biweekly patient diary.

Results

Five patients (mean age, 41 years) were included. Standard treatment resulted in marked improvement in one patient, partial benefit in three, and no response in one. The four patients with persistent symptoms subsequently underwent the FTP protocol, achieving additional pain reduction. Symptom recurrence generally required repeat treatment at 5–6‐month intervals.

Conclusions

BoNT‐A appears effective for FBS. In patients with persistent or partially controlled symptoms, a symptom‐guided FTP strategy may provide additional benefit within a stepwise management approach. Level of Evidence 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ANeuromuscular AgentsHumansAdultFemaleMalePain MeasurementTreatment OutcomeMiddle AgedSyndromeUltrasonography, InterventionalFollow-Up Studies

Stichwörter der Autor:innen

First Bite Syndromebotulinum toxin type ahead and neck surgerypainpostoperative complication

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Section of Otorhinolaryngology-Head and Neck Surgery, Department of Neuroscience (DNS), University of Padova, Padova, Italy.
  • Department of Life Science, Health, and Health Professions, Link Campus University, Rome, Italy.
  • Department of Biomechanical Diseases, School of Dentistry, University of Siena, Siena, Italy.
  • Department of Clinical and Experimental Medicine, Physical Medicine and Rehabilitation Unit, University of Messina, Messina, Italy.

ORCID-Profile: Rosario Marchese-Ragona, Gianmarco Giunta, Daniele Manfredini

Zitieren

APA

Marchese-Ragona, R., Giunta, G., Adamo, D., Zanoletti, E., Manfredini, D., & Restivo, D. A. (2026). Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy. Head & Neck, 48(12), 3447-3455. https://doi.org/10.1002/hed.70378

Vancouver

Marchese-Ragona R, Giunta G, Adamo D, Zanoletti E, Manfredini D, Restivo DA. Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy. Head & Neck. 2026;48(12):3447-3455. doi:10.1002/hed.70378

BibTeX
@article{MarcheseRagona2026,
  author = {Marchese-Ragona, Rosario and Giunta, Gianmarco and Adamo, Daniela and Zanoletti, Elisabetta and Manfredini, Daniele and Restivo, Domenico Antonio},
  title = {Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy},
  journal = {Head & Neck},
  year = {2026},
  volume = {48},
  number = {12},
  pages = {3447--3455},
  doi = {10.1002/hed.70378}
}
Kostenlos starten →